Literature DB >> 2021532

The influence of chronic anaemia on the radiosensitivity of two mouse tumours.

A C Koong1, D G Hirst.   

Abstract

There is clear clinical evidence that tumours in anaemic patients are difficult to control with radiotherapy. We have studied the radiosensitivity of two transplantable mouse tumours, the SCCVII/St carcinoma and the KHT sarcoma in hosts made anaemic either with an iron poor diet or as a result of tumour growth. The haemoglobin level and haematocrits of mice on the low iron diet fell to about 60% of normal within 11 weeks. The number of clonogenic cells after a single X-ray dose of 20 Gy was slightly lower (P less than 0.05) in the anaemic animals (2.3 X 10(4) g-1) than in controls (5.2 X 10(4) g-1) though there was no significant difference in the surviving fractions. Mice bearing KHT tumours became anaemic with haematocrits falling to 65% of normal as their tumours grew from 300-1200 mg. A second 'test' tumour was implanted one week after the first 'anaemia-inducing' tumour so that estimates of radiosensitivity could all be carried out on tumours within the same size range (150-300 mg). Radiosensitivity was significantly greater in the most anaemic hosts with 2.2 X 10(4) cells g-1 surviving a dose of 20 Gy compared with 6.7 x 10(4) g-1 in controls (P less than 0.01). These results are consistent with most published data for mouse tumours though not for many human tumours.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021532      PMCID: PMC1972338          DOI: 10.1038/bjc.1991.119

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  [The influence of anemia on the radiation effect in transplanted tumours. Studies on the fructose sarcoma].

Authors:  N Tanaka; M Maeda; M Hasegawa
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1969-04

2.  The effect of anaemia on the fraction of hypoxic cells in an experimental tumour.

Authors:  R P Hill; R S Bush; P Yeung
Journal:  Br J Radiol       Date:  1971-04       Impact factor: 3.039

3.  Carcinoma of the cervix--anaemia, radiotherapy and hyperbaric oxygen.

Authors:  S Dische; P J Anderson; R Sealy; E R Watson
Journal:  Br J Radiol       Date:  1983-04       Impact factor: 3.039

4.  The in vivo radiation response of an experimental tumor: the effect of exposing tumor-bearing mice to a reduced oxygen environment prior to but not during irradiation.

Authors:  D W Siemann; R P Hill; R S Bush; P Chhabra
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-01       Impact factor: 7.038

5.  Chronic anaemia, hyperbaric oxygen and tumour radiosensitivity.

Authors:  M McCormack; A H Nias; E Smith
Journal:  Br J Radiol       Date:  1990-10       Impact factor: 3.039

Review 6.  Anemia: a problem or an opportunity in radiotherapy?

Authors:  D G Hirst
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-11       Impact factor: 7.038

7.  Tumor blood flow and O2 availability during hemodilution.

Authors:  C Jung; W Müller-Klieser; P Vaupel
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

8.  The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15.

Authors:  J T Fazekas; C Scott; V Marcial; L W Davis; T Wasserman; J S Cooper
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-12       Impact factor: 7.038

9.  Effect of induced host anaemia on the viability and radiosensitivity of murine malignant cells in vivo.

Authors:  H B Hewitt; E R Blake
Journal:  Br J Cancer       Date:  1971-06       Impact factor: 7.640

10.  Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.

Authors:  D G Hirst; J M Brown; J L Hazlehurst
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

View more
  2 in total

Review 1.  Erythropoietin or darbepoetin for patients with cancer.

Authors:  Thomy Tonia; Annette Mettler; Nadège Robert; Guido Schwarzer; Jerome Seidenfeld; Olaf Weingart; Chris Hyde; Andreas Engert; Julia Bohlius
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

2.  The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse.

Authors:  B Joiner; V K Hirst; S R McKeown; J J McAleer; D G Hirst
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.